ID: 225 | Pages: 136 | December 2016 | Region: Asia Pacific
Asia-Pacific market for Cardiovascular Diagnostic and Monitoring Devices was worth $298.18 million in 2015 and estimated to be growing at a CAGR of 7.5%, to reach $428 million by 2020. Cardiovascular disease is a medical condition which affects the structure and function of organs associated with function of heart and its circulation
Cardio Vascular diseases are the major cause of death and witnessing a high rise in prevalence. There are a large number of people being diagnosed with cardiovascular diseases such as periphery artery diseases, coronary artery diseases, congenital heart diseases, and pulmonary conditions shifting focus towards preventative healthcare.
Asia-Pacific market for cardiovascular monitoring is driven by factors such as increasing risks related to hypertension and heart muscle weakening, growing number of people suffering from diabetes and obesity. Advancements in technology which enabled portability features in performing various tests are further boosting the growth of Cardiovascular Monitoring devices market. However unclear reimbursement policies, economic instability, strict government regulations for product approvals and high cost of monitoring devices are some of the major restraining factors for the market growth.
Asia-Pacific cardiovascular monitoring devices market is analysed on the basis of product which is segmented into ECG systems, Holter Monitors, Event Monitors, Implantable loop recorders and ECG management systems. Electrocardiographs segment is further sub segmented into Resting ECG systems and Stress ECG systems. ECG systems is the largest product segment accounting for a share of approximately XX% in the market and expected to maintain its strong hold during the forecast period due to increasing preference for these devices.
On the basis of geography Asia-Pacific market for cardiovascular diagnostic and monitoring devices market is segmented into various regions namely China, India, Japan and South Korea. Asia-Pacific is estimated to be the fastest growing region due to rising awareness about the effectiveness of accessible devices in successfully curing several cardio vascular conditions and increasing healthcare spending.
Asia-Pacific Cardiovascular monitoring devices market is dominated by GE healthcare and Phillips dominated the global Cardiovascular Monitoring and Diagnostic Devices Market accounting for a approximately 50% share. Other major companies covered in the report are Siemens Healthcare, Boston Scientific Corporation, St. Jude Medical, Inc., Nihon Kohden Corporation, and Welch Allyn, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.1 ECG Systems
5.1.1.1 Resting ECG Systems
5.1.1.2 Stress ECG Systems
5.1.2 Event Monitors
5.1.3 Holter Monitors
5.1.4 Implantable Loop Recorders
5.1.5 ECG Management Systems
6. Geographical Analysis
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Philips Healthcare
8.3 Siemens Healthcare
8.4 Boston Scientific Corporation
8.5 St. Jude Medical, Inc
8.6 Nihon Kohden Corporation
8.7 Welch Allyn, Inc.
8.8 Spacelabs Healthcare
8.9 LivaNova PLC
8.10 Hill-Rom Holdings, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Title | Price | Add To Cart |
© 2018 Market Data Forecast
All Rights Reserved.